Are You Looking For Medical Devices Certifications?
Get it here!Looking for Regulatory Consultant ?
Placing an in vitro diagnostic (IVD) medical device on the EU market requires manufacturers to demonstrate compliance with Regulation (EU) 2017/746 (IVDR) through well-structured and comprehensive technical documentation. This documentation provides clear evidence that the product meets all applicable safety, performance, and regulatory requirements under the IVDR.
Robust technical documentation is essential for ensuring transparency, traceability, and a streamlined CE marking process. It enables regulatory authorities and notified bodies to assess product compliance more effectively and facilitates smoother market access within the European Union.
The technical documentation for In Vitro Diagnostic (IVD) medical devices is a comprehensive regulatory file that manufacturers must prepare to demonstrate conformity with applicable requirements under Regulation (EU) 2017/746 (IVDR). This documentation serves as formal evidence that the device meets the essential safety and performance requirements necessary for CE marking and market access in the European Union.
IVDR technical documentation typically includes a detailed description of the device and its specifications, along with references to previous and similar device generations. It also covers design and development information, General Safety and Performance Requirements, pre-clinical and analytical testing data, performance evaluation results, and a thorough risk management process. Each of these elements plays a critical role in demonstrating the device’s overall compliance and reliability under the regulatory framework.
Equally important is the structure and organisation of the technical file. The documentation must be clear, well-organised, and easy to navigate, with information presented logically and unambiguously. This enables regulatory authorities and notified bodies to efficiently assess the device’s safety, performance, and intended use, ensuring it performs as expected without posing unacceptable risks to patients/users or any other persons.
At Maven Profcon Services LLP, we support manufacturers at every stage of IVDR technical documentation preparation. Our team provides end-to-end assistance with the preparation of a complete IVDR technical file; gap assessment of existing technical documentation, where it exists, and its structuring in accordance with Annex II and Annex III; compilation of performance evaluation and risk management files; and review of existing documentation for compliance. We work closely with clients to ensure their technical files are accurate, audit-ready, and aligned with notified body expectations, thereby accelerating CE certification and ensuring long-term regulatory compliance.

This section provides a clear, detailed description of the IVD device, including its intended purpose, operating principles, and classification. It also covers device variants, configurations, and any associated accessories. Information on materials, components, and key functional characteristics helps regulators fully understand the product.
This includes all labelling and information supplied by the manufacturers, such as Instructions for Use (IFU), packaging labels, and promotional content. The information must be accurate, consistent, and compliant with IVDR requirements to ensure users can safely and effectively operate the device.
Contains information on the process from initial design through final production. It should give an overview of the processes involved, including how quality is maintained and how consistency is ensured across batches.
This section explains how the device meets the applicable General Safety and Performance Requirements under IVDR. It should clearly identify which requirements apply to the device based on its intended purpose and justify any that are not applicable. For each applicable requirement, the requirement must be described, the approach used to demonstrate conformity must be described, and the approach must be supported by appropriate evidence. This typically includes references to harmonised standards, Common Specifications (CS), or other accepted methods and solutions used to ensure compliance. The goal is to present a clear, traceable link between regulatory requirements and supporting documentation in the technical file.
This section focuses on how device-related risks are identified, evaluated, and controlled, and demonstrates that the overall benefits outweigh the potential risks. It should include a clear benefit-risk analysis in line with the relevant sections of Annex I, explaining why the device can be considered safe and effective for its intended use. In addition, the documentation must describe the risk management process followed, including the measures implemented to reduce or eliminate risks and the outcomes of those measures. Altogether, this section should provide a transparent view of how safety has been built into the device throughout its lifecycle.
It includes the results and critical analysis of all verification and validation tests and/or studies conducted to demonstrate conformity of the device to the requirements of the Regulation, particularly the applicable General Safety and Performance Requirements. This section covers documents such as the Analytical and Clinical Performance Study Protocols and Reports, as well as the Performance Evaluation Plan (PEP) and Performance Evaluation Report (PER), which include information on the analytical performance, clinical performance, and supporting clinical evidence of the device.
In addition, it includes stability data, demonstrating the shelf life, transport stability, and in-use stability of the device under defined conditions, where applicable. It also covers software verification and validation (where applicable), along with any additional information required for specific device types or situations.
Post-market surveillance is a continuous process carried out after the device is placed on the market to ensure it remains safe and performs as intended in real-world use. This section includes a Post-Market Surveillance (PMS) Plan that outlines how data will be systematically collected, reviewed, and analysed throughout the device lifecycle. It also covers the preparation of Periodic Safety Update Reports (PSUR) depending on the class of the device, Post-market Surveillance Reports to summarise post-market findings, assess emerging risks, and confirm that the benefit-risk profile remains acceptable. Together, these activities help identify issues early and support timely corrective actions, ensuring ongoing compliance and patient safety.
This section outlines the key regulatory and organisational details for the device. It typically includes manufacturer information, details of the authorised representative (if applicable), certificates, legal documents, etc. Properly maintained administrative information ensures traceability, supports regulatory review, and keeps all documentation aligned and up to date throughout the product lifecycle.
For further information on IVDR Technical Documentation, refer to the following document:
Technical documentation under the In Vitro Diagnostic Regulation (IVDR) comprises the set of documents an IVD device manufacturer prepares to demonstrate that its product complies with the applicable safety and performance requirements set out in Regulation (EU) 2017/746 (IVDR). This documentation covers the device’s description, design, manufacturing processes, performance evaluation, risk management, labelling, and scientific validity, among other elements. It is evidence for notified bodies to assess and verify that the device is safe, effective, and performs as intended. The technical documentation must be maintained and updated based on PMS inputs.
Under the IVDR, the structure and content of technical documentation are primarily defined in Annexes II and III of Regulation (EU) 2017/746. Annex II outlines what should be included in the main technical file. It covers key elements like device description, design and manufacturing details, general safety and performance requirements, risk management, and performance evaluation.
Annex III, on the other hand, deals with post-market aspects. It outlines the requirements for monitoring the device after it is placed on the market, including the Post-Market Surveillance (PMS) plan and related activities.
Together, these two annexes provide a clear, practical framework for preparing IVDR technical documentation, ensuring the device is not only compliant at certification but also remains safe and effective throughout its lifecycle.
IVDR technical documentation is essential for CE marking, as it demonstrates that an In-Vitro Diagnostic (IVD) medical device meets the safety, performance, and regulatory requirements of the EU IVDR. It provides detailed evidence that the device is safe, performs as intended, and poses no undue risk to users, patients or any other persons. This documentation is reviewed by notified bodies and regulators to verify compliance. Without complete and accurate technical documentation, CE certification cannot be granted, restricting the device from being marketed in the EU. Therefore, it is a critical foundation for regulatory approval, market access, and maintaining compliance throughout the product lifecycle.